PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
REGN vs. VHT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between REGN and VHT is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

REGN vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

0.00%2,000.00%4,000.00%6,000.00%8,000.00%AugustSeptemberOctoberNovemberDecember2025
4,486.68%
592.07%
REGN
VHT

Key characteristics

Sharpe Ratio

REGN:

-1.17

VHT:

0.26

Sortino Ratio

REGN:

-1.53

VHT:

0.42

Omega Ratio

REGN:

0.80

VHT:

1.05

Calmar Ratio

REGN:

-0.62

VHT:

0.24

Martin Ratio

REGN:

-1.44

VHT:

0.66

Ulcer Index

REGN:

18.45%

VHT:

4.41%

Daily Std Dev

REGN:

22.74%

VHT:

11.28%

Max Drawdown

REGN:

-91.81%

VHT:

-39.12%

Current Drawdown

REGN:

-43.28%

VHT:

-9.57%

Returns By Period

In the year-to-date period, REGN achieves a -4.32% return, which is significantly lower than VHT's 1.91% return. Over the past 10 years, REGN has underperformed VHT with an annualized return of 4.94%, while VHT has yielded a comparatively higher 8.74% annualized return.


REGN

YTD

-4.32%

1M

-4.62%

6M

-35.92%

1Y

-26.71%

5Y*

12.08%

10Y*

4.94%

VHT

YTD

1.91%

1M

2.36%

6M

-3.83%

1Y

2.86%

5Y*

7.08%

10Y*

8.74%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

REGN vs. VHT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN
The Risk-Adjusted Performance Rank of REGN is 66
Overall Rank
The Sharpe Ratio Rank of REGN is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of REGN is 44
Sortino Ratio Rank
The Omega Ratio Rank of REGN is 55
Omega Ratio Rank
The Calmar Ratio Rank of REGN is 1111
Calmar Ratio Rank
The Martin Ratio Rank of REGN is 77
Martin Ratio Rank

VHT
The Risk-Adjusted Performance Rank of VHT is 1212
Overall Rank
The Sharpe Ratio Rank of VHT is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of VHT is 1111
Sortino Ratio Rank
The Omega Ratio Rank of VHT is 1111
Omega Ratio Rank
The Calmar Ratio Rank of VHT is 1515
Calmar Ratio Rank
The Martin Ratio Rank of VHT is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

REGN vs. VHT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for REGN, currently valued at -1.17, compared to the broader market-2.000.002.004.00-1.170.26
The chart of Sortino ratio for REGN, currently valued at -1.53, compared to the broader market-4.00-2.000.002.004.00-1.530.42
The chart of Omega ratio for REGN, currently valued at 0.80, compared to the broader market0.501.001.502.000.801.05
The chart of Calmar ratio for REGN, currently valued at -0.62, compared to the broader market0.002.004.006.00-0.620.24
The chart of Martin ratio for REGN, currently valued at -1.44, compared to the broader market-10.000.0010.0020.00-1.440.66
REGN
VHT

The current REGN Sharpe Ratio is -1.17, which is lower than the VHT Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of REGN and VHT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-1.17
0.26
REGN
VHT

Dividends

REGN vs. VHT - Dividend Comparison

REGN has not paid dividends to shareholders, while VHT's dividend yield for the trailing twelve months is around 1.50%.


TTM20242023202220212020201920182017201620152014
REGN
Regeneron Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VHT
Vanguard Health Care ETF
1.50%1.53%1.36%1.33%1.14%1.21%1.89%1.38%1.31%1.45%1.22%1.02%

Drawdowns

REGN vs. VHT - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for REGN and VHT. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-43.28%
-9.57%
REGN
VHT

Volatility

REGN vs. VHT - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 9.43% compared to Vanguard Health Care ETF (VHT) at 3.77%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
9.43%
3.77%
REGN
VHT
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab